Dr. Salem Baldi | Cancer Diagnosis | Best Researcher Award Posted on 21/10/202421/10/2024 by Pencis Dr. Salem Baldi | Cancer Diagnosis | Best Researcher Award Shaoyang University | China Author Profile Scopus ORCID ID Google Scholar 🌍Dr. Salem Baldi, Ph.D. Associate Professor, Medical Laboratory Diagnostics🔬: 🧬Biography: Dr. Salem Baldi is an esteemed Associate Professor at the Department of Medical Laboratory Diagnostics, Shaoyang University, China. With a strong background in biochemistry, molecular biology, and clinical diagnostics, he has made noteworthy contributions to cancer research and genetic diagnostics 🧬. He previously worked as a Biochemistry Research Scientist at Anxuyuan Biotechnology in Shenzhen, where he applied his expertise in molecular diagnostics. Dr. Baldi holds a Ph.D. in Clinical Laboratory Diagnostics from Dalian Medical University and a Master’s in Molecular Genetics from Jiamusi University, China. His research expertise spans cancer cell biology, DNA library preparation, and advanced genetic techniques such as CRISPR/Cas9 for disease modeling. 🧫 Fluent in English, Arabic, and Chinese, Dr. Baldi is deeply engaged in the global scientific community, holding memberships in the European Society for Blood and Marrow Transplantation and the Arab Society of Genetic Counselors. His remarkable dedication to science has earned him numerous awards, recognizing his impact in both academic and scientific circles. 🏅 Beyond his professional life, Dr. Baldi enjoys soccer, badminton, tennis, traveling, reading, and gardening ⚽🌿📚. 🧪Research Interests: Cancer Diagnostics 🧫 Molecular Genetics 🧬 Clinical Laboratory Science 🧪 Innovative Approaches in Medical Research 🌱 📊Skills & Expertise: Mammalian Cell Culture (Primary and Cancer Cells) Molecular Cloning, Transfection, Gene Expression PCR, qPCR, Real-Time PCR 🔬 Western Blotting, SDS-PAGE, Immunofluorescence DNA Library Preparation (NGS, Illumina, PacBio) 📊 CRISPR/Cas9 Disease Modeling 🧬 🏅Awards & Recognitions: 2021: Excellence in Scientific Research 🏅, Yemeni Ministry of Higher Education 2022: Certificate of Gratitude 🙏, Yemeni Students Union, China 🌍Languages: English Arabic Chinese ✨Conclusion: 🌱Dr. Salem Baldi is a dedicated researcher and educator, committed to advancing the field of medical laboratory diagnostics. His expertise in molecular biology and biochemistry, coupled with a global perspective and fluency in multiple languages, positions him as a leader in cancer research and diagnostics. His passion for integrating traditional and modern medical practices drives his innovative approach to improving patient outcomes. Beyond the lab, his diverse interests reflect a well-rounded individual who is deeply engaged in both his personal and professional pursuits. ✨ 📊🔬NOTABLE PUBLICATION: Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study Authors: Alradhi, M., Safi, M., Tao, S., Baldi, S., Li, X. Journal: Therapeutic Advances in Urology Year: 2022 Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study Authors: Al-Danakh, A., Safi, M., Alradhi, M., Zhu, X., Yang, D. Journal: Cells Year: 2022 ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression Authors: Baldi, S., Zhang, Q., Zhang, Z., Al-Nusaif, M., Zuo, Y. Journal: Journal of Cellular and Molecular Medicine Year: 2022 Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data Authors: Baldi, S., He, Y., Ivanov, I., Gao, Y., Tian, H. Journal: Frontiers in Molecular Biosciences Year: 2022 Unraveling the salt tolerance of Phi29 DNA polymerase using compartmentalized self-replication and microfluidics platform Authors: Sun, Y., Ko, D.H., Gao, J., He, Y., Tian, H. Journal: Frontiers in Microbiology Year: 2023
Dr. Honghong Zhu | Colorectal Cancer | Best Researcher Award Posted on 09/09/202409/09/2024 by Pencis Dr. Honghong Zhu | Colorectal Cancer | Best Researcher Award Zhejiang Chinese Medical University | China Author Profile Scopus Biography of Hong-Hong Zhu, MD, MSc, PhD – Professor of Extraordinary Ability 🎓🌍 🎯 Current Role: Leader in Medical Research Dr. Hong-Hong Zhu is the Head of the Center for Medical Research at Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (Quzhou Hospital of TCM). Her leadership in medical research spans over three decades. 📜 Educational Background Ph.D. in Epidemiology from Johns Hopkins University (JHU) Bloomberg School of Public Health (2007) Postdoctoral Training at the U.S. National Institutes of Health (NIH) MD & Master’s Degree in Medicine from Zhejiang University M.Sc. from Clemson University 💡 Key Contributions: Breast Cancer Etiology Pioneer Dr. Zhu was the first to propose the Synergistic Interaction Theory for breast cancer, linking environmental carcinogens and exogenous hormone use. Her work has significantly advanced the understanding of cancer causes. 🔬 Innovator in Colorectal Cancer Prevention With 32 years of research in colorectal cancer prevention, Dr. Zhu and her team developed cost-effective screening methods that have saved millions of lives worldwide. 🏆 Academic Achievements and Awards 135 Publications in esteemed journals 35 Awards, including: Best Poster Award (NIH) for breast cancer research (2006) Delta Omega Honor from the U.S. National Public Health Honor Society (2007) Second Place in Scientific Competition in Epidemiology and Public Health (2007) Professor of Extraordinary Ability (2015) Sigma Xi Scientific Research Honor (2024) 📚 Editor and Peer Reviewer Editor-in-Chief of the Journal of GHR (since 2015) Peer Reviewer for academic journals for over 20 years Grant Reviewer for the U.S. Department of Health and Human Services (12 years) Dr. Hong-Hong Zhu’s contributions to medical research have made her a global figure in epidemiology and cancer prevention. 🔍 Conclusion With over three decades of research in epidemiology and disease prevention, Dr. Hong-Hong Zhu has made groundbreaking contributions in breast and colorectal cancer research. Her innovative approaches to cancer screening and prevention have been life-saving on a global scale. She remains a recognized leader in public health, continuing to inspire through her research, publications, and numerous honors. 🌟 📊🔬NOTABLE PUBLICATION: Combining FITs and HRFQ with colonoscopy improve the cost-effectiveness of a 9-year mass colorectal cancer screening program Authors: Cai, S.-R., Huang, Y.-Q., Li, Q.-R., Yang, J.-H., Zheng, S. Journal: ESMO Open Year: 2024 Sex difference in alcohol consumption associated with colorectal cancer risk in Quzhou, China: A nested case-control study Authors: Lai, S.-M., Zhu, H.-H., Gan, Z.-J., Wang, Z.-C., Liao, X.-F. Journal: Preventive Medicine Reports Year: 2024 Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years Authors: Zhu, H.-H., Sun, G.-Q., Wu, J.-Y., Wang, Z.-C., Liao, X.-F. Journal: Frontiers in Immunology Year: 2023